HALO logo
halo search icon
Arcus Biosciences, Inc.
Arcus Biosciences, Inc.
RCUS · NYS

Arcus Biosciences, Inc.

US$23.74

Price Arrow0.99 (4.35%)
20/05/2026 04:10:00 PM
All-CompaniesAll-ConsensusHALO AllHALO MomentumRecent Earnings upgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Arcus Biosciences, Inc. Overview

RCUS Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Very Strong

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About RCUS

icon

Telephone

1.510.694.6200

icon

Address

3928 Point Eden Way, Hayward, CA 94545

Description

Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology, and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.

RCUS Price Chart

Key Stats

Market Cap

US$2.86B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 7.91 - 28.72

Trade Value (12mth)

US$5,918,027.00

1 week

-4.33%

1 month

-7.22%

YTD

-2.32%

1 year

164.23%

All time high

49.10

Key Fundamentals

EPS 3 yr Growth

-11.40%

EBITDA Margin

-152.20%

Operating Cashflow

-$482m

Free Cash Flow Return

-66.60%

ROIC

-48.80%

Interest Coverage

-47.00

Quick Ratio

4.40

Other Data

Shares Outstanding (Fully Diluted)

125m

HALO Sector

Healthcare

Next Company Report Date

02-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

RCUS Announcements

Latest Announcements

DateAnnouncements
06 May 26
06 May 26
06 May 26
06 May 26
20 April 26

RCUS Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-4.15-3.14-3.29locklocklock
EPS (Fully Diluted)
$locklocklocklock-4.15-3.14-3.29locklocklock
Growth
%locklocklocklock-11.924.3-4.6locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Arcus Biosciences, Inc. (RCUS:NYS)?
Halo FAQ
The current share price of Arcus Biosciences, Inc. (RCUS:NYS) is USD$23.74.
What is the 52-week high share price for Arcus Biosciences, Inc. (RCUS:NYS)?
Halo FAQ
The 52-week high share price for Arcus Biosciences, Inc. (RCUS:NYS) is USD$28.72.
What is the 52-week low share price for Arcus Biosciences, Inc. (RCUS:NYS)?
Halo FAQ
The 52-week low share price for Arcus Biosciences, Inc. (RCUS:NYS) is USD$7.91.
What is the dividend yield for Arcus Biosciences, Inc. (RCUS:NYS)?
Halo FAQ
Arcus Biosciences, Inc. (RCUS:NYS) does not pay a dividend.
What was Arcus Biosciences, Inc. (RCUS:NYS) last dividend payment?
Halo FAQ
Arcus Biosciences, Inc. (RCUS:NYS) does not pay a dividend.
What is the franking level for Arcus Biosciences, Inc. (RCUS:NYS)?
Halo FAQ
Arcus Biosciences, Inc. (RCUS:NYS) has a franking level of 0.00%.
In which sector is Arcus Biosciences, Inc. (RCUS:NYS) classified?
Halo FAQ
Arcus Biosciences, Inc. (RCUS:NYS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.